These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 19336927

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Tannate complexes of antihistaminic drug: sustained release and taste masking approaches.
    Rahman Z, Zidan AS, Berendt RT, Khan MA.
    Int J Pharm; 2012 Jan 17; 422(1-2):91-100. PubMed ID: 22037447
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
    Lai F, Pini E, Corrias F, Perricci J, Manconi M, Fadda AM, Sinico C.
    Int J Pharm; 2014 Jun 05; 467(1-2):27-33. PubMed ID: 24680963
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Taste-masked and affordable donepezil hydrochloride orally disintegrating tablet as promising solution for non-compliance in Alzheimer's disease patients.
    Liew KB, Tan YT, Peh KK.
    Drug Dev Ind Pharm; 2015 Apr 05; 41(4):583-93. PubMed ID: 24495273
    [Abstract] [Full Text] [Related]

  • 30. Development and optimization of taste-masked orally disintegrating tablets (ODTs) of clindamycin hydrochloride.
    Cantor SL, Khan MA, Gupta A.
    Drug Dev Ind Pharm; 2015 Apr 05; 41(7):1156-64. PubMed ID: 25000481
    [Abstract] [Full Text] [Related]

  • 31. Formulation and evaluation of taste-masked levocetirizine dihydrochloride orally disintegrating tablets.
    Devireddy SR, Gonugunta CS, Veerareddy PR.
    PDA J Pharm Sci Technol; 2009 Apr 05; 63(6):521-6. PubMed ID: 20169858
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Investigation of Chloroquine Resinate Feasibility and In Vitro Taste Masking Evaluation for Pediatric Formulations.
    Guimarães TF, Vital ICF, de Sousa EGR, Boniatti J, Bandini TB, Carr O, Oliveira ON, Shimizu FM, da Fonseca LB, Viçosa AL.
    AAPS PharmSciTech; 2022 Feb 02; 23(2):69. PubMed ID: 35112208
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. In vitro and in vivo investigation of taste-masking effectiveness of Eudragit E PO as drug particle coating agent in orally disintegrating tablets.
    Drašković M, Medarević D, Aleksić I, Parojčić J.
    Drug Dev Ind Pharm; 2017 May 02; 43(5):723-731. PubMed ID: 27494420
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Complexation of risperidone with a taste-masking resin: novel application of near infra-red and chemical imaging to evaluate complexes.
    Tawakkul MA, Shah RB, Zidan A, Sayeed VA, Khan MA.
    Pharm Dev Technol; 2009 May 02; 14(4):409-21. PubMed ID: 19630698
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Formulation and characterization of patient-friendly dosage form of ondansetron hydrochloride.
    Bhoyar P, Biyani D, Umekar M.
    J Young Pharm; 2010 Jul 02; 2(3):240-6. PubMed ID: 21042478
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.